Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Oct 07, 2024 1:33pm
47 Views
Post# 36256417

RE:RE:RE:Reposted - may explain the large BID versus ASK

RE:RE:RE:Reposted - may explain the large BID versus ASK
Solid1 wrote: Stada at least had the size to push through the necessary reforms in Germany... the removal from the narcotics list and now the abolition of the health insurance reservation And the preference for finished drugs plays into the hands of companies like Medipharm labs and Stada... Big Pharma... this deal already has weight - just don't panic 


You're making alot of assumptions and excuses on behalf of Stada.  We have been told they are #2 in oils in Germany and yet that status doesn't appear to benefit Medipharm at all.  I'm sure Stada has the might to drive reforms, it's just not clear if they are pushing and driving sales as our most important partner in Western Europe.  Something with the Stada partnership has never added up.
<< Previous
Bullboard Posts
Next >>